Aerie Pharmaceuticals, Inc. Names Vicente Anido, Jr. as Chairman of the Board, and David Epstein as Chairman of Aerie’s Scientific Advisory Board

Published: Apr 04, 2013

Aerie Pharmaceuticals, Inc. announced today that Vicente Anido, Jr., Ph.D., was named Chairman of Aerie’s Board of Directors. Dr. Anido is a well-respected ophthalmology industry veteran and leader, who most recently served as President and Chief Executive Officer of ISTA Pharmaceuticals prior to its acquisition by Bausch + Lomb. Aerie also announced that David Epstein, M.D., Chairman, Department of Ophthalmology, Duke University School of Medicine, and Aerie Co-Founder, has been named as Chairman of the Company’s Scientific Advisory Board.

Back to news